温胃健脾活血汤联合替普瑞酮治疗萎缩性胃炎伴幽门螺杆菌感染临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.32

基金项目:


Clinical Study on Wenwei Jianpi Huoxue Decoction Combined with Teprenone for Atrophic Gastritis Complicated with Helicobacter Pylori Infection
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察温胃健脾活血汤联合替普瑞酮治疗萎缩性胃炎伴幽门螺杆菌(Hp) 感染的临床疗效及 对血清胃泌素释放肽前体(ProGRP) 与糖链抗原242 (CA242) 水平的影响。方法:采用随机数字抽签法将 110例萎缩性胃炎伴Hp感染患者分为治疗组、对照组各55例。对照组给予替普瑞酮治疗,治疗组采用温胃健 脾活血汤联合替普瑞酮治疗,2组均治疗2个月。比较2组临床疗效、Hp清除率及随访1个月Hp复发率;比较 2组治疗前后中医证候积分、血清ProGRP、CA242、胃动素、胃泌素水平。结果:治疗组总有效率、Hp清除 率分别为94.55%、90.91%,高于对照组81.82%、74.55% (P<0.05)。2组治疗后中医证候积分(胃脘胀满、 疲倦乏力、四肢不温、大便溏薄) 及血清ProGRP、CA242水平均低于治疗前(P<0.05),胃动素、胃泌素水 平均高于治疗前(P<0.05),治疗组治疗后中医证候积分及血清ProGRP、CA242 水平均低于对照组(P< 0.05),胃动素、胃泌素水平均高于对照组(P<0.05)。治疗后1个月随访,治疗组Hp复发率20.00%,低于对 照组56.10%(P<0.05)。治疗组不良反应发生率10.91%,对照组不良反应发生率5.45%,2组比较,差异无统 计学意义(P>0.05)。结论:温胃健脾活血汤联合替普瑞酮治疗萎缩性胃炎伴Hp感染疗效确切,能够改善患者 胃功能,降低血清ProGRP与CA242水平,降低Hp复发,安全性高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Wenwei Jianpi Huoxue Decoction combined with Teprenone on atrophic gastritis complicated with helicobacter pylori (Hp) infection and its effect on levels of pro-gastrin releasing peptide (ProGRP) and carbohydrate antigen 242 (CA242) in serum. Methods:A total of 110 patients with atrophic gastritis complicated with Hp infection were divided into the treatment group and the control group according to the random number drawing method, with 55 cases in each group. The control group was treated with Teprenone, and the treatment group was treated with Wenwei Jianpi Huoxue Decoction combined with Teprenone. Both groups were treated for 2 months. The clinical effects, Hp clearance rate,and 1-month follow-up Hp recurrence rates were compared between the two groups. Before and after treatment, the traditional Chinese medicine (TCM) syndrome scores, and levels of ProGRP, CA242, motilin, and gastrin in serum were compared between the two groups. Results: The total effective rate and Hp clearance rate were 94.55% and 90.91% respectively in the treatment group, which were higher than those of 81.82% and 74.55% in the control group (P<0.05). After treatment,the TCM syndrome scores (distention and fullness in the stomach cavity, fatigue and lack of strength, cold limbs, and thin and unformed stool) and the levels of serum ProGRP and CA242 were lower than those before treatment (P<0.05); the levels of motilin and gastrin in the two groups were higher than those before treatment (P<0.05). After treatment, the TCM syndrome scores and the levels of serum ProGRP and CA242 were lower than those in the control group (P<0.05); the levels of motilin and gastrin were higher than those in the control group (P<0.05). After one month of follow-up after treatment, the Hp recurrence rate was 20.00% in the treatment group, lower than that of 56.10% in the control group (P< 0.05). The incidence of adverse reactions was 10.91% in the treatment group, and 5.45% in the control group, there being no significance in the difference (P>0.05). Conclusion: The combination of Wenwei Jianpi Huoxue Decoction and Teprenone has a definite curative effect on atrophic gastritis with Hp infection. It can improve the patient's gastric function, reduce levels of ProGRP and CA242 in serum, reduce Hp recurrence,and has high safety.

    参考文献
    相似文献
    引证文献
引用本文

毛晶晶,李舟涛.温胃健脾活血汤联合替普瑞酮治疗萎缩性胃炎伴幽门螺杆菌感染临床研究[J].新中医,2024,56(9):66-70

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-13
  • 出版日期:
文章二维码